Drug Trial Radar · NCT02586909
12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension
Last checked: Nov 19, 2026Latest source record: Apr 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,099
Actual
Start
Apr 26, 2016
Primary completion
Mar 12, 2018
Study completion Mar 12, 2018
Sponsor
- Lead sponsor
- Axovant Sciences Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 27, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 50 years, up to 86 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This 12-month open-label study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who have completed the double-blind, placebo-controlled, lead-in study RVT-101-3001 (double-blind study).
Conditions
- Alzheimer's Disease
Interventions
RVT-101 35 mg tabletsDrug
once daily, oral tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of Adverse Events (AEs) and or Reported Changes in Physical Examinations, Vital Signs Measurements, Electrocardiograms (ECGs), Routine Laboratory AssessmentsTime frame: Baseline to 12 months or Early Termination
Locations
169 sites in 19 countries. Site status is shown where the registry gives one.
US112
Phoenix, Arizona
US220
Tucson, Arizona
US096
Rancho Mirage, California
US195
Santa Ana, California
US016
Simi Valley, California
US106
Temecula, California
US179
Hamden, Connecticut
US171
Norwich, Connecticut
US088
Atlantis, Florida
US007
Brooksville, Florida
US002
Hallandale, Florida
US140
Hialeah, Florida
US216
Miami, Florida
US110
Miami, Florida
US172
North Palm Beach, Florida
US003
Orlando, Florida
US256
Pensacola, Florida
US037
Tampa, Florida
US042
Tampa, Florida
US004
The Villages, Florida
US048
Atlanta, Georgia
US046
Atlanta, Georgia
US217
Columbus, Georgia
US111
Baton Rouge, Louisiana
US095
Shreveport, Louisiana
US116
Newton, Massachusetts
US174
Quincy, Massachusetts
US144
Hattiesburg, Mississippi
US094
Las Vegas, Nevada
US135
Berlin, New Jersey
US197
Lawrenceville, New Jersey
US215
Mount Arlington, New Jersey
US057
Paterson, New Jersey
US209
Toms River, New Jersey
US036
West Long Branch, New Jersey
US001
Albany, New York
US049
Brooklyn, New York
US097
New Hyde Park, New York
US044
New York, New York
US150
Chapel Hill, North Carolina
Showing 40 of 169 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.